Compare Annaly Capital Management, Inc. (NLY) vs Organon & Co. Common Stock (OGN) Price & Performance

Annaly Capital Management (NLY) trades at $18.16, down 0.71% with a bearish technical outlook despite strong fundamentals. The mortgage REIT shows robust profitability with 92.77% net income margin and 20.66% ROE, trading below book value at P/B of 0.91. Recent earnings beats and a $0.75 quarterly dividend yielding approximately 16.5% highlight income appeal, though cash flow volatility and rising leverage pose concerns.

NLY presents a high-yield opportunity with significant analyst upside to $22 consensus target, but faces headwinds from interest rate sensitivity and portfolio expansion risks. The stock's attractive valuation and dividend sustainability must be weighed against mREIT sector volatility and the company's substantial debt load increasing to 23.55 debt-to-asset ratio in 2025.

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.